Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, announced a collaborative initiative to accelerate innovation in digital pathology (DP) and artificial intelligence (AI) for oncology research and clinical ca…
Merck, known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for $221.50 per sh…
SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, announced a global research and licensing collaboration with Eli Lilly and Company . The companies will collaborate to advance RNAi candidates for metabolic diseases, based on SanegeneBio's proprietary tissue selective deliver…
Brenntag, the global market leader in chemicals and ingredients distribution, announced a new and exclusive distribution agreement with ArcticZymes AS on the salt-active nucleases: SAN HQ, SAN-HQ GMP, M-SAN HQ, M-SAN HQ GMP, developed for the efficient removal of nucleic acids in gene therapy, vaccine production and o…
Complete Genomics, a leading innovator in genomic sequencing, announced a collaboration with SOPHiA GENETICS, a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics' DNBSEQ-T1+ sequencing platform. The companies aim to broaden …
Evinova, a global health-tech company accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, and Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, announ…
NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medical University in Osaka, Japan. Under the guidance of Dr. Toshio Shimizu as the Director of the Phase I program, Kansai Medical University will now offer patients in Japan the opportunity to participa…
Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi, a global leader in AI drug discovery, announced a strategic platform-based collaboration with Eli Lilly and Company ("Lilly") to accelerate the discovery and development of bispecific antibodies for the treatment of various diseases.…
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND", announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR-T cells. This agreement represents…
Insurance leader Vitality and Google today announced a global partnership to launch Vitality AI. This new platform will integrate Google Cloud's advanced AI and data analytics, with Vitality's vast health datasets and behavior-change expertise, to transform how millions worldwide understand and manage their health. Th…
Page 24 of 37